Arcutis Biotherapeutics, Inc. (ARQT) vs Viridian Therapeutics, Inc. (VRDN)

• Arcutis Biotherapeutics, Inc. ARQT 25.55 ▼ −5.37%
• Viridian Therapeutics, Inc. VRDN 28.50 ▼ −0.18%

Arcutis Biotherapeutics, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Arcutis Biotherapeutics, Inc. and Viridian Therapeutics, Inc. are of similar size ($3.4B and $3.2B). Viridian Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 112×. Arcutis Biotherapeutics, Inc. grew revenue faster over the last twelve months: 60.0% against −62.8%. Arcutis Biotherapeutics, Inc. has the higher net margin (5.88% vs −1,724.1%) and the higher return on invested capital (23.5% vs 0.00%). Across the 17 metrics below, Arcutis Biotherapeutics, Inc. leads on 12 and Viridian Therapeutics, Inc. on 5.